Deepcell: Mark Aitkenhead
Mark Aitkenhead has been appointed as chief commercial officer of Deepcell, a new position at the Menlo Park, California-based single-cell analysis company. He comes to Deepcell from next-generation sequencing firm Element Biosciences, where he had the same role. Before that, he held various positions at Thermo Fisher Scientific, including general manager for cellular analysis instrumentation and global commercial leader for the clinical next-generation sequencing division. Aitkenhead obtained a PhD in anatomy and a bachelor's degree in biomedical sciences from Queen's University of Belfast in Northern Ireland.